Home › Chronic Myeloid Leukemia › Texas › Houston

Pag-aaral pangklinika para sa Chronic Myeloid Leukemia sa Houston, TX

Isang pag-aaral para sa Chronic Myeloid Leukemia ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Houston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

UT MD Anderson Cancer Center, Houston

Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Nagre-recruitObservasyonal na pag-aaral

Texas Children's Hospital, Houston

Edad 0 hanggang 38 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06131801

Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Chronic Myeloid Leukemia in Chronic Phase After Failing One Prior Therapy With a Second Generation Tyrosine Kinase Inhibitor or Asciminib

Nagre-recruitPhase 2

MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06817720

Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

Nagre-recruitPhase 2

The University of Texas M. D. Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07269470

Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.

Nagre-recruitPhase 2

MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06236724

Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

Nagre-recruitPhase 1

M D Anderson Cancer Center, Houston

Edad 1 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT03630991

Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib

Nagre-recruitPhase 2

M D Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT01746836

Study of Olverembatinib (HQP1351) in Patients With CML-CP

Nagre-recruitPhase 3

Ascentage Investigative Site #1501, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06423911

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Nagre-recruitObservasyonal na pag-aaral

M.D. Anderson Cancer Center, Houston
Texas Children's Hospital - Baylor Medical Center, Houston

Lahat ng edad · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT01351545

Asciminib Roll-over Study

Nagre-recruitPhase 4

Uni Of TX MD Anderson Cancer Cntr, Houston

Edad 7 hanggang 100 · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT04877522

Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia

Nagre-recruitPhase 2

M D Anderson Cancer Center, Houston

Edad 18 hanggang 65 · Lahat ng kasarian · Na-update May 20, 2026 · NCT02115295

Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial

Nagre-recruitObservasyonal na pag-aaral

University of Texas MD Anderson Cancer Center, Houston

Lahat ng edad · Lahat ng kasarian · Na-update Abr 16, 2026 · NCT00816114

A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia

Nagre-recruitPhase 1

The University of Texas MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 1, 2026 · NCT05304377

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Nagre-recruitPhase 2

MD Anderson, Houston

Edad 18 hanggang 66 · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT06859424

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

Nagre-recruitPhase 1

MD Anderson Cancer Center, Houston

Edad 12 pataas · Lahat ng kasarian · Na-update Mar 16, 2026 · NCT06994676

A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)

Nagre-recruitPhase 1/2

The University of Texas M.D. Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 12, 2026 · NCT06163430

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

Nagre-recruitPhase 1

University of Texas MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2025 · NCT04260022

TGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia

Nagre-recruitPhase 1

The University of Texas MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 21, 2025 · NCT06088888

Pag-aaral para sa Chronic Myeloid Leukemia sa ibang lungsod

Iba pang pag-aaral sa Houston

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.